The <i><scp>KIT</scp></i><scp>D</scp>816<scp>V</scp> allele burden predicts survival in patients with mastocytosis and correlates with the <scp>WHO</scp> type of the disease
Gregor Hoermann(University of Freiburg), Wolfgang R. Sperr(Medical University of Vienna), Georg Greiner(Ludwig Boltzmann Institute Applied Diagnostics), Friedrich Wimazal, Emir Hadzijusufovic(University of Veterinary Medicine Vienna), Karoline V. Gleixner(Medical University of Vienna), Graziella E. Dinu(Fachhochschule Wiener Neustadt), Christine Mannhalter(Medical University of Vienna), Michael Kundi(Medical University of Vienna), Gerlinde Mitterbauer(Medical University of Vienna), Peter Valent(Medical University of Vienna)
Cited by 103
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496